
News from Research & Development World
Information about Research & Development World
Where is Research & Development World located?Research & Development World's WebsiteResearch & Development World's TwitterMedia Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Research & Development World News

Nobel Prize · SwedenThe physics award is the second 2025 Nobel Prize to be announced this week. Three scientists at American universities won the 2025 Nobel Prize in Physics for their work on quantum mechanics. The winners are John Clarke, Michel H. Devoret, and John M. Martinis.See the Story
Nobel Prize in physics goes to trio of researchers for discoveries in quantum mechanics
45% Center coverage: 266 sources

Nobel Prize · SwedenThe 2025 Nobel Prize in physiology or medicine has been awarded to a trio of scientists for their discoveries “concerning peripheral immune tolerance.” Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi will share the prize for their work on how to prevent the immune system from harming the body.See the Story
The Nobel Prize in medicine goes to 3 scientists for work on peripheral immune tolerance
42% Center coverage: 254 sources

Glenn Youngkin · VirginiaAstraZeneca Plc (NASDAQ:AZN) on Thursday said it will invest $4.5 billion in its new manufacturing facility in Virginia, a proposed increase of $500 million to support the enhanced manufacturing capability of a broader range of medicines, including cancer treatments. This is part of the historic $50 billion investment announced in July 2025. The new facility will be located at Rivanna Futures in Albemarle County, creating approximately 3,600 dir…See the Story
AstraZeneca Expands Virginia Investment To $4.5 Billion For Cancer, Obesity Drugs - AstraZeneca (NASDAQ:AZN)
57% Center coverage: 14 sources